Ruti Levy

3 weeks ago | haaretz.com | Ruti Levy

Nisim Perets pulls a small test tube from his bag. A translucent, pea-size white lump floats gently in the tube. "This is a brain," he says. "These are brain cells from a child on the autism spectrum. We grew it from urine." This is no metaphor but rather, a three-dimensional tissue of human brain cells cultivated in lab conditions. It is capable of reacting to stimuli, sending electrical signals and even – according to preliminary tests – learning.

Jan 13, 2025 | haaretz.com | Ruti Levy

The technology of QRGenetics identifies the activity of defective proteins in children with ultra-rare disease with no cure, and seeks out existing drugs for other uses – that may change the course of the disease.

Dec 22, 2024 | haaretz.com | Ruti Levy

Just four months after a giant seed round, Decart has raised another $32 million. Its software speeds up AI training, but investors – and the gamers community – are drawn to its generative game modelRuti LevyDec 22, 2024 9:16 pm ISTDec 22, 2024 9:16 pm ISTSend in e-mailSend in e-mail Ruti LevyDec 22, 2024 9:16 pm ISTDec 22, 2024 9:16 pm ISTIsraeli startup Decart, formed by veterans of the army's 8200 intelligence unit, is a game changer. In the most literal sense.

Dec 9, 2024 | haaretz.com | Ruti Levy

According to a new study by RISE, the number of new Israeli technology companies has plummeted by 45 percent in the past decade. The rate of major successes is also alarmingRuti LevyDec 10, 2024 12:15 pm ISTDec 10, 2024 12:15 pm ISTSend in e-mailSend in e-mail Ruti LevyDec 10, 2024 12:15 pm ISTDec 10, 2024 12:15 pm IST"Everything will be okay" is the narrative accompanying the consistent and ongoing decline in the number of new startups being established in Israel.

Feb 10, 2024 | haaretz.com | Ruti Levy

When EyeControl embarked on its road in 2016, the startup's founders could not have foreseen the terrible timing at which its product would mature, and become a key tool in care at intensive care units. Dr. Ami Mayo [SP], Head of the Intensive care unit (ICU) at the Assuta Ashdod public hospital, admits he was surprised when a patient, who awoke intensely agitated, calmed down when the company's device, a light-weight headband with an earphone and a camera, was placed on his head.